Global Custom-Compounded Therapy Market Overview:
Bioidentical hormone therapy is another name for custom compounded therapy. Man-made hormones that are equivalent to hormones produced by the human body are known as bioidentical hormones. Bioidentical hormones are used to treat men and women who have low or unbalanced hormone levels.
- Increasing demand for personalized medicine
- Increasing in side effects of humans
- Increasing knowledge in consumers
- Increasing demand for customized compound therapies in few years due to awareness of health
The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth.
Some of the key players profiled in the report are Fagron (Netherlands), Specialist Pharmacy (United Kingdom), Nova Laboratories (United Kingdom), Athenex Pharma Solutions (New York), ImprimisRx (California), Fresenius Kabi (Germany), Baxter (United States), B. Braun (Germany) and Galenic Laboratories (France). Additionally, following companies can also be profiled that are part of our coverage like Pencol Compounding Pharmacy (United States), McKesson Corporation (United States) and Clinigen Group (United Kingdom). Analyst at AMA Research see United States Players to retain maximum share of Global Custom-Compounded Therapy market by 2026. Considering Market by Distribution Channel, the sub-segment i.e. Hospital pharmacy will boost the Custom-Compounded Therapy market. Considering Market by Therapeutic Area, the sub-segment i.e. Hormone replacement will boost the Custom-Compounded Therapy market.
In 2021, MEDISCA declared that in June it would equal up to USD 100,000 in donations to the Alliance for Pharmacy Compounding, Media Fund Campaign, encouraging investments to support APC’s nationwide marketing and lobbying effort to secure compounded hormone therapy.
What Can be Explored with the Custom-Compounded Therapy Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Custom-Compounded Therapy Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Custom-Compounded Therapy
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Custom-Compounded Therapy market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Custom-Compounded Therapy market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Frequently Asked Questions (FAQ):1. What is the growth rate predicted for the Global Custom-Compounded Therapy Market?
The Custom-Compounded Therapy market is expected to see a CAGR of % during projected year 2020 to 2026.
2. Who are the top performing companies in Custom-Compounded Therapy Market?
Top performing companies in the Global Custom-Compounded Therapy market are Fagron (Netherlands), Specialist Pharmacy (United Kingdom), Nova Laboratories (United Kingdom), Athenex Pharma Solutions (New York), ImprimisRx (California), Fresenius Kabi (Germany), Baxter (United States), B. Braun (Germany) and Galenic Laboratories (France), to name a few.
3. What trending factors would impact Custom-Compounded Therapy Market growth most?
"New therapy are developing" is seen as one of major influencing trends for Custom-Compounded Therapy Market during projected period 2020-2026.